Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Sales | 1,675 | 5,326 | 1,962 | 7,966 | 3,320 |
| Cost of Goods | 3,353 | 3,657 | 3,278 | 4,569 | 4,790 |
| Gross Profit | -1,678 | 1,669 | -1,316 | 3,397 | -1,460 |
| Operating Expenses | 3,524 | 3,292 | 2,527 | 3,116 | 3,600 |
| Operating Income | -4,849 | -966 | -3,565 | 850 | -4,280 |
| Interest Expense | 1,023 | 925 | 1,019 | 946 | 180 |
| Other Income | -86 | -12 | -12 | -10 | -20 |
| Pre-tax Income | -5,958 | -1,903 | -4,596 | -106 | -4,480 |
| Income Tax | N/A | N/A | N/A | N/A | -90 |
| Net Income Continuous | -5,958 | -1,903 | -4,596 | -106 | -4,393 |
| Net Income | $-5,958 | $-1,903 | $-4,596 | $-106 | $-4,393 |
| EPS Basic Total Ops | -20.00 | -6.50 | -15.00 | -0.50 | -15.00 |
| EPS Basic Continuous Ops | -19.82 | -6.33 | -15.32 | -0.35 | -15.04 |
| EPS Diluted Total Ops | -20.00 | -6.50 | -15.00 | -0.50 | -15.00 |
| EPS Diluted Continuous Ops | -19.82 | -6.33 | -15.32 | -0.35 | -15.04 |
| EBITDA(a) | $-4,099 | $92 | $-2,714 | $1,678 | $-3,522 |